HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rotraut Mössner Selected Research

Rotraut Mössner Research Topics

Disease

23Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 01/2002
6Psoriatic Arthritis
11/2023 - 06/2007
5Melanoma (Melanoma, Malignant)
07/2016 - 09/2002
4Pityriasis Rubra Pilaris
01/2024 - 03/2019
4Neoplasms (Cancer)
07/2016 - 09/2002
3Rheumatoid Arthritis
01/2022 - 09/2008
3Inflammation (Inflammations)
06/2011 - 06/2004
2Lichen Planus (Lichen Ruber Planus)
01/2022 - 12/2021
2Pyoderma
01/2022 - 01/2022
2Arthritis (Polyarthritis)
01/2022 - 05/2019
2Eosinophilic Fasciitis
12/2021 - 08/2021
2Acrodermatitis (Gianotti Crosti Syndrome)
10/2021 - 01/2019
2Multiple Sclerosis
01/2021 - 04/2016
2Hypersensitivity (Allergy)
01/2011 - 12/2003
1Erythema
01/2023
1Hidradenitis Suppurativa
11/2022
1Localized Scleroderma (Morphea)
12/2021
1Body Weight (Weight, Body)
12/2021
1Sclerosis
12/2021
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
08/2021
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
08/2021
1Nicolau Syndrome
01/2021
1Injection Site Reaction
01/2021
1Skin Diseases (Skin Disease)
03/2019
1Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2018
1Ankylosing Spondylitis
01/2018
1Central Nervous System Diseases (CNS Diseases)
01/2018
1Chronic Mucocutaneous Candidiasis
04/2016
1Granuloma Annulare
03/2016
1Necrosis
01/2011
1Contact Dermatitis (Eczema, Contact)
01/2011

Drug/Important Bio-Agent (IBA)

6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 01/2002
5Methotrexate (Mexate)FDA LinkGeneric
11/2023 - 11/2012
5Infliximab (Remicade)FDA Link
01/2018 - 03/2008
5Proteins (Proteins, Gene)FDA Link
07/2012 - 09/2002
4Adalimumab (Humira)FDA Link
01/2018 - 09/2008
4Etanercept (Enbrel)FDA Link
01/2018 - 09/2008
3upadacitinibIBA
01/2022 - 12/2021
3risankizumabIBA
08/2021 - 10/2020
3Interleukin-17 (Interleukin 17)IBA
01/2019 - 04/2016
3Tumor Necrosis Factor InhibitorsIBA
01/2009 - 03/2008
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2007 - 09/2002
2bimekizumabIBA
01/2024 - 12/2023
2apremilastIBA
01/2023 - 05/2019
2Interleukin-23 (Interleukin 23)IBA
10/2021 - 02/2009
2InterleukinsIBA
07/2018 - 01/2002
2AntibodiesIBA
07/2016 - 09/2008
2Glutathione Transferase (Glutathione S-Transferase)IBA
01/2011 - 01/2007
2Interleukin-16 (Interleukin 16)IBA
01/2011 - 12/2003
2PPAR gammaIBA
02/2007 - 09/2002
2PPAR alphaIBA
06/2004 - 09/2002
2LigandsIBA
06/2004 - 09/2002
2CytokinesIBA
12/2003 - 01/2002
1Immunoglobulin A (IgA)IBA
11/2023
1Anti-Bacterial Agents (Antibiotics)IBA
11/2022
1tofacitinibIBA
01/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
12/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2021
1GlucocorticoidsIBA
12/2021
1Prednisolone (Predate)FDA LinkGeneric
08/2021
1Rituximab (Mabthera)FDA Link
08/2021
1Glatiramer Acetate (Copaxone)FDA Link
01/2021
1guselkumabIBA
11/2020
1tildrakizumabIBA
11/2020
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
05/2019
1brodalumabIBA
05/2019
1Interleukin-17 ReceptorsIBA
05/2019
1Isotretinoin (Accutane)FDA LinkGeneric
03/2019
1Lipocalin-2IBA
04/2018
1AfatinibIBA
02/2018
1Ustekinumab (CNTO 1275)FDA Link
01/2017
1Monoclonal AntibodiesIBA
07/2016
1Immune Checkpoint InhibitorsIBA
07/2016
1ruxolitinibIBA
04/2016
1Interferon-betaIBA
04/2016
1VemurafenibIBA
03/2016
1Leflunomide (Arava)FDA LinkGeneric
01/2015
1AcitretinFDA Link
01/2015
1FumaratesIBA
01/2015
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2015
125-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
07/2012
11,25-dihydroxyvitamin DIBA
07/2012
1Genetic Markers (Genetic Marker)IBA
07/2012
1Mixed Function Oxygenases (Monooxygenases)IBA
07/2012
1Vitamin DFDA LinkGeneric
07/2012
1Vitamin D-Binding ProteinIBA
07/2012
1Calcitriol Receptors (Calcitriol Receptor)IBA
07/2012
1Vitamin D3 24-HydroxylaseIBA
07/2012
1ParaffinIBA
06/2011
1Anti-Idiotypic AntibodiesIBA
06/2011
1Formaldehyde (Formol)FDA Link
06/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2011
1N-acetyltalosaminuronic acid (NAT)IBA
01/2011
1Filaggrin ProteinsIBA
01/2011
1Irritants (Vesicants)IBA
01/2011
1Superoxide DismutaseIBA
01/2011

Therapy/Procedure

10Therapeutics
11/2023 - 03/2008
1Aftercare (After-Treatment)
12/2021
1Intra-Articular Injections
01/2021
1Subcutaneous Injections
01/2021